메뉴 건너뛰기




Volumn 16, Issue 6 A, 1996, Pages 3341-3348

Biochemically targeted therapy of refractory leukemia and myeloid blast crisis of chronic granulocytic leukemia with Tiazofurin, a selective blocker of inosine 5′-phosphate dehydrogenase activity

Author keywords

Granulocytic leukemia; Refractory leukemia; Targeted therapy; Tiazofurin

Indexed keywords

ALLOPURINOL; GUANOSINE PHOSPHATE; GUANOSINE TRIPHOSPHATE; HYPOXANTHINE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; OXIDOREDUCTASE; TIAZOFURIN;

EID: 0030499040     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (53)

References (11)
  • 1
    • 0027722155 scopus 로고
    • Therapy-related myelodysplasia and acute myeloma leukemia. Cytogenetic charaeteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen Series
    • Pederson-Gjergaard J, Philip P, Larsen SO, Andersson M, Daugaard G, Ersboll J, Hansen SW, Hou-Jensen K, Nielsen D, Sigsgaard TC, Specht L and Osterlind K: Therapy-related myelodysplasia and acute myeloma leukemia. Cytogenetic charaeteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in The Copenhagen Series. Leukemia 7: 1975-1986, 1993.
    • (1993) Leukemia , vol.7 , pp. 1975-1986
    • Pederson-Gjergaard, J.1    Philip, P.2    Larsen, S.O.3    Andersson, M.4    Daugaard, G.5    Ersboll, J.6    Hansen, S.W.7    Hou-Jensen, K.8    Nielsen, D.9    Sigsgaard, T.C.10    Specht, L.11    Osterlind, K.12
  • 3
    • 0017364109 scopus 로고
    • Enzymology of cancer cells
    • Weber G Enzymology of cancer cells. N Engl J Med 296: 486-493, 541-551, 1977.
    • (1977) N Engl J Med , vol.296 , pp. 486-493
    • Weber, G.1
  • 4
    • 0020955571 scopus 로고
    • Biochemical strategy of cancer cells and the design of chemotherapy. GHA Clowes Memorial Lecture
    • Weber G: Biochemical strategy of cancer cells and the design of chemotherapy. GHA Clowes Memorial Lecture. Cancer Res 43:3466-3492, 1983.
    • (1983) Cancer Res , vol.43 , pp. 3466-3492
    • Weber, G.1
  • 5
    • 0016907181 scopus 로고
    • Key enzymes of IMP metabolism: Transformation- And proliferation-linked alterations in gene expression
    • Weber G, Prajda N, Jackson RC. Key enzymes of IMP metabolism: transformation- and proliferation-linked alterations in gene expression. Advan Enzyme Regul 14: 3-24, 1976.
    • (1976) Advan Enzyme Regul , vol.14 , pp. 3-24
    • Weber, G.1    Prajda, N.2    Jackson, R.C.3
  • 6
    • 0020466967 scopus 로고
    • Nucleoside and nucleotide inhibitors of inosine monophosphate (IMP) dehydrogenase as potential antitumor inhibitors
    • Robins RK: Nucleoside and nucleotide inhibitors of inosine monophosphate (IMP) dehydrogenase as potential antitumor inhibitors. Nucleosides & Nucleotides 1: 35-44, 1982.
    • (1982) Nucleosides & Nucleotides , vol.1 , pp. 35-44
    • Robins, R.K.1
  • 7
    • 0022626497 scopus 로고
    • Phase I and pharmacokinetic study of tiazofurin (NSC 286193) administered by 5-day continuous infusion
    • Raghavan D, Bishop J, Sampson D, et al: Phase I and pharmacokinetic study of tiazofurin (NSC 286193) administered by 5-day continuous infusion. Cancer Chemother Pharmacol 16: 160-164, 1986.
    • (1986) Cancer Chemother Pharmacol , vol.16 , pp. 160-164
    • Raghavan, D.1    Bishop, J.2    Sampson, D.3
  • 8
    • 0021932321 scopus 로고
    • Phase I clinical study with pharmacokinetic analysis of 2-β-D-ribofuranosyithiazole-4-carboxamide (NSC 286193) administered as a five day infusion
    • Trump DL, Tutsch RD, Koeller JN, Tormey DC. Phase I clinical study with pharmacokinetic analysis of 2-β-D-ribofuranosyithiazole-4-carboxamide (NSC 286193) administered as a five day infusion. Cancer Res 45: 2853-2858, 1985.
    • (1985) Cancer Res , vol.45 , pp. 2853-2858
    • Trump, D.L.1    Tutsch, R.D.2    Koeller, J.N.3    Tormey, D.C.4
  • 9
    • 0023092448 scopus 로고
    • Phase I trial of tiazofurin administered by iv bolus daily for 5 days, with pharmacokinetic evaluation
    • Roberts JD, Stewart JA, McCormack JJ, et al. Phase I trial of tiazofurin administered by iv bolus daily for 5 days, with pharmacokinetic evaluation. Cancer Treat Rep 71: 141-149, 1987.
    • (1987) Cancer Treat Rep , vol.71 , pp. 141-149
    • Roberts, J.D.1    Stewart, J.A.2    McCormack, J.J.3
  • 10
    • 0022403035 scopus 로고
    • Pediatric phase I trial and pharmacokinetic study of tiazofurin (NSC 286193)
    • Balis FM, Lange BL, Packer RJ, et al: Pediatric phase I trial and pharmacokinetic study of tiazofurin (NSC 286193). Cancer Res 45: 5169-5172, 1985.
    • (1985) Cancer Res , vol.45 , pp. 5169-5172
    • Balis, F.M.1    Lange, B.L.2    Packer, R.J.3
  • 11
    • 0021971512 scopus 로고
    • Phase I evaluation of pharmacokinetics of tiazofurin (2-β-D-ribofuranosylthiazole-4-carboxamide. NSC 286193)
    • Melink TJ, Von Hoff DD, Kuhn JG, et al: Phase I evaluation of pharmacokinetics of tiazofurin (2-β-D-ribofuranosylthiazole-4-carboxamide. NSC 286193). Cancer Res 45: 2859-2865, 1985.
    • (1985) Cancer Res , vol.45 , pp. 2859-2865
    • Melink, T.J.1    Von Hoff, D.D.2    Kuhn, J.G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.